Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens External Web Site Icon K Parikh et al, JAMA Network Open, February 28, 2020

Hot Topics of the Day|PHGKB

What's New

Last Posted: Mar 01, 2020

---

• Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens 
  K Parikh et al, JAMA Network Open, February 28, 2020
• Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field. 
  Yanes Tatiane et al. Breast cancer research : BCR 2020 Feb 22(1) 21
• Comparing an artificial neural network to logistic regression for predicting ED visit risk among patients with cancer: a population-based cohort study. 
  Sutradhar Rinku et al. Journal of pain and symptom management 2020 Feb
• A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. 
  Hermanns Thomas et al. Urologic oncology 2020 Feb
• Automatic Recognition of Laryngoscopic Images Using a Deep-Learning Technique. 
  Ren Jianjun et al. The Laryngoscope 2020 Feb
• Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN). 
  Galot Rachel et al. Cancer treatment reviews 2020 Feb 85101992
• Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma. 
  Zhang Yingying et al. Medical science monitor : international medical journal of experimental and clinical research 2020 Feb 26e919644
• External Validation of a Deep Learning Model for Predicting Mammographic Breast Density in Routine Clinical Practice. 
  Dontchos Brian N et al. Academic radiology 2020 Feb
• Germline mutation in 1,338 BRCA-negative Chinese hereditary breast and/or ovarian cancer patients: clinical testing with a multigene test panel. 
  Kwong Ava et al. The Journal of molecular diagnostics : JMD 2020 Feb
• Improving Oral Cancer Outcomes with Imaging and Artificial Intelligence. 
  Ilhan B et al. Journal of dental research 2020 Mar 99(3) 241-248
• Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma. 
  Gerke Julia S et al. International journal of cancer 2020 146(7) 2036-2046
• Italian Men Tested for BRCA1/2 Mutation: Psychological Distress during 6-Month Follow-Up. 
  Pellini F et al. Journal of oncology 2020 20203987935
• miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil. 
  Pessôa-Pereira Danielle et al. BMC cancer 2020 Feb 20(1) 143
• Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention. 
  Sellami Maha et al. Nutrients 2020 Feb 12(2)
• Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma. 
  Gu Hui-Yun et al. Aging 2020 Feb 12